We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
all report title image

BIOPHARMA BUFFER MARKET ANALYSIS

Biopharma Buffer Market, By Type (Pre-formulated Buffers, Customized Buffers, Concentrated Buffers, Others), By Application (Cell Culture, Purification, Formulation), By End User (Biopharmaceutical Companies, Contract Research Organizations, Academic & Research Institutes), By Buffer Component (Amino Acids, Acetic Acid, Phosphate, Histidine, Others), By Buffer Preparation (Liquid, Powder), By Material Form (Dry, Liquid), By Region (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)

  • Published In : Apr 2023
  • Code : CMI5649
  • Pages :158
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Market News

Biopharma Buffer Market Recent Developments -

New product launches

  1. "Sartobind AAV" by Sartorius AG: In 2020, Sartorius AG launched a new line of pre-packed membrane adsorbers specifically designed for the purification of adeno-associated virus (AAV) particles.
  2. "BioPAT® Xgas" by Sartorius AG: In 2021, Sartorius AG launched a new online gas analyzer for monitoring dissolved gases in biopharmaceutical processes, which can be used to optimize buffer preparation.
  3. "J.T.Baker® Dry Powder Buffers" by Avantor: In 2020, Avantor launched a new line of dry powder buffers, which are designed to offer improved stability, solubility, and reproducibility compared to traditional liquid buffers.
  4. "BufferEZ™" by Bio-Rad Laboratories: In 2020, Bio-Rad Laboratories launched a new line of pre-formulated buffer solutions for use in protein purification applications.
  5. "KANEKA KanCapA" by Kaneka Corporation: In 2021, Kaneka Corporation launched a new line of animal-free caprylic acid-based buffers for use in protein A chromatography.

Acquisition and partnerships

  1. In 2020, Avantor announced its acquisition of Ritter GmbH, a manufacturer of bioprocessing equipment and systems, in order to expand its capabilities in the biopharmaceutical market.
  2. In 2019, Merck KGaA announced a partnership with Avantor to develop and distribute high-quality single-use technology products for biopharmaceutical manufacturing.
  3. In 2018, GE Healthcare announced its acquisition of Puridify, a company that specializes in developing nanofiber-based purification technologies for biopharmaceutical manufacturing.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.